XZ

Xiaofan Zheng

BS Bristol-Myers Squibb: 25 patents #164 of 3,969Top 5%
📍 Cheshire, CT: #29 of 532 inventorsTop 6%
🗺 Connecticut: #1,400 of 34,797 inventorsTop 5%
Overall (All Time): #151,364 of 4,157,543Top 4%
26
Patents All Time

Issued Patents All Time

Showing 1–25 of 26 patents

Patent #TitleCo-InventorsDate
11866430 Naphthyridinone compounds useful as T cell activators Louis S. Chupak, Min Ding, Robert G. Gentles, Yazhong Huang, Scott W. Martin +5 more 2024-01-09
11713316 Substituted naphthyridinone compounds useful as T cell activators Upender Velaparthi, Louis S. Chupak, Chetan Padmakar Darne, Min Ding, Robert G. Gentles +16 more 2023-08-01
10954238 Substituted naphthyridinone compounds useful as T cell activators Upender Velaparthi, Louis S. Chupak, Chetan Padmakar Darne, Min Ding, Robert G. Gentles +16 more 2021-03-23
10669272 Substituted naphthyridinone compounds useful as T cell activators Upender Velaparthi, Louis S. Chupak, Chetan Padmakar Darne, Min Ding, Robert G. Gentles +16 more 2020-06-02
10517870 Aryl substituted bicycle heteroaryl compounds Xiaojun Zhang, Louis S. Chupak 2019-12-31
9872852 Compounds useful as immunomodulators Louis S. Chupak 2018-01-23
9850225 Compounds useful as immunomodulators Louis S. Chupak, Min Ding, Scott W. Martin, Piyasena Hewawasam, Timothy P. Connolly +5 more 2017-12-26
8404741 Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase Louis S. Chupak, Min Ding, Shuanghua Hu, Yazhong Huang, Robert G. Gentles 2013-03-26
8354548 Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase Shuanghua Hu, Yazhong Huang, Min Ding, Louis S. Chupak, Robert G. Gentles 2013-01-15
8133884 Compounds for the treatment of hepatitis C Scott W. Martin, Carl P. Bergstrom, Min Ding, Robert G. Gentles 2012-03-13
7547690 Compounds for the treatment of Hepatitis C Robert G. Gentles, Min Ding, Yong Tu, Ying Han, Piyasena Hewawasam +5 more 2009-06-16
7541353 Compounds for the treatment of hepatitis C Robert G. Gentles, Min Ding, Yong Tu, Ying Han, Piyasena Hewawasam +5 more 2009-06-02
7521441 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Robert G. Gentles, Piyasena Hewawasam, Min Ding, Carl P. Bergstrom, Scott W. Martin +4 more 2009-04-21
7485633 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Nicholas A. Meanwell, Robert G. Gentles, Min Ding, John A. Bender, John F. Kadow +2 more 2009-02-03
7473688 Indolobenzazepine HCV NS5B inhibitors Carl P. Bergstrom, John A. Bender, Robert G. Gentles, Piyasena Hewawasam, Thomas W. Hudyma +6 more 2009-01-06
7399758 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Nicholas A. Meanwell, Robert G. Gentles, Min Ding, John A. Bender, John F. Kadow +2 more 2008-07-15
7348425 Inhibitors of HCV replication Thomas W. Hudyma, Feng He, Min Ding, Carl P. Bergstrom, Piyasena Hewawasam +2 more 2008-03-25
7153848 Inhibitors of HCV replication Thomas W. Hudyma, Feng He, Min Ding, Carl P. Bergstrom, Piyasena Hewawasam +2 more 2006-12-26
7022667 O-derivatized nocathiacin derivatives Thomas W. Hudyma, B. Narasimhulu Naidu, Margaret E. Sorenson, Alicia Regueiro-Ren, Timothy P. Connolly +7 more 2006-04-04
6803374 Compounds useful for treating hepatitis C virus Eldon Scott Priestley, Carl P. Decicco, Thomas W. Hudyma 2004-10-12
6620934 Water soluble prodrugs of azole compounds Thomas W. Hudyma, Oak K. Kim 2003-09-16
6620799 Water soluble prodrugs of azole compounds Thomas W. Hudyma, Oak K. Kim 2003-09-16
6486159 Water soluble prodrugs of azole compounds Thomas W. Hudyma, Oak K. Kim 2002-11-26
6458961 Water soluble prodrugs of azole compounds Thomas W. Hudyma, Oak K. Kim 2002-10-01
6359141 Water soluble prodrugs of azole compounds Thomas W. Hudyma, Oak K. Kim 2002-03-19